The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sintilimab (IBI308) in relapsed/refractory classical Hodgkin lymphoma: A multicenter, single-arm phase 2 trial in China (ORIENT-1 study).
 
Yuankai Shi
No Relationships to Disclose
 
Hang Su
No Relationships to Disclose
 
Yongping Song
No Relationships to Disclose
 
Wenqi Jiang
No Relationships to Disclose
 
Xiuhua Sun
No Relationships to Disclose
 
Wenbin Qian
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Yuhuan Gao
No Relationships to Disclose
 
Zhengming Jin
No Relationships to Disclose
 
Jianfeng Zhou
No Relationships to Disclose
 
Chuan Jin
No Relationships to Disclose
 
Liqun Zou
No Relationships to Disclose
 
Lugui Qiu
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Jianmin Yang
No Relationships to Disclose
 
Ming Hou
No Relationships to Disclose
 
Shan Zeng
No Relationships to Disclose
 
Peng Liu
No Relationships to Disclose
 
Hui Zhou
Employment - Suzhou Kintor Pharmaceuticals
Stock and Other Ownership Interests - Suzhou Kintor Pharmaceuticals
 
Xiao Li
Employment - Suzhou Kintor Pharmaceuticals
Stock and Other Ownership Interests - Suzhou Kintor Pharmaceuticals